M. Kulyk & Associates
AMGN icon

M. Kulyk & Associates’s Amgen AMGN Stock Holding History

M. Kulyk & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$312K Hold
741
– – 0.05% 85
2026
Q2 		$268K Sell
741
-405
-35% -$139K 0.04% 103
2026
Q1 		$403K Sell
1,146
-328
-22% -$117K 0.08% 82
2025
Q4 		$483K Sell
1,474
-62
-4% -$19.7K 0.09% 68
2025
Q3 		$434K Sell
1,536
-21,991
-93% -$6.38M 0.09% 68
2025
Q2 		$6.57M Buy
23,527
+1,205
+5% +$341K 1.43% 25
2025
Q1 		$6.95M Sell
22,322
-94
-0.4% -$27.8K 1.59% 21
2024
Q4 		$5.84M Sell
22,416
-144
-0.6% -$42.7K 1.26% 30
2024
Q3 		$7.27M Sell
22,560
-235
-1% -$76.9K 1.46% 26
2024
Q2 		$7.12M Buy
22,795
+569
+3% +$167K 1.65% 21
2024
Q1 		$6.32M Sell
22,226
-168
-0.8% -$49.2K 1.47% 24
2023
Q4 		$6.45M Sell
22,394
-944
-4% -$257K 1.5% 26
2023
Q3 		$6.27M Buy
23,338
+545
+2% +$136K 1.74% 15
2023
Q2 		$5.06M Buy
22,793
+573
+3% +$133K 1.41% 28
2023
Q1 		$5.37M Buy
22,220
+733
+3% +$180K 1.63% 24
2022
Q4 		$5.64M Buy
21,487
+63
+0.3% +$16.9K 1.88% 15
2022
Q3 		$4.83M Buy
21,424
+401
+2% +$97.2K 1.68% 17
2022
Q2 		$5.12M Buy
21,023
+358
+2% +$87.7K 1.59% 19
2022
Q1 		$5M Sell
20,665
-5,203
-20% -$1.2M 1.36% 27
2021
Q4 		$5.82M Buy
25,868
+1,639
+7% +$346K 1.51% 26
2021
Q3 		$5.15M Buy
24,229
+1,583
+7% +$364K 1.65% 21
2021
Q2 		$5.52M Buy
22,646
+1,996
+10% +$491K 1.99% 15
2021
Q1 		$5.14M Buy
20,650
+6,296
+44% +$1.5M 1.92% 13
2020
Q4 		$3.3M Buy
+14,354
New +$3.31M 1.83% 22

Other funds holding AMGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

M. Kulyk & Associates's AMGN Position: Q3 2026 in Review

M. Kulyk & Associates held its Amgen (AMGN) position steady in Q3 2026 at 741 shares worth $312K. The position accounts for 0.05% of the portfolio, ranked #85.

M. Kulyk & Associates first reported a position in AMGN in Q4 2020 and has held it in 24 quarters since. The position peaked at $7.27M in Q3 2024. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • M. Kulyk & Associates held 741 shares of Amgen worth $312K as of Q3 2026.
  • M. Kulyk & Associates left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.05% of M. Kulyk & Associates's portfolio in Q3 2026, its #85 holding.
  • M. Kulyk & Associates first reported a position in Amgen in Q4 2020 and has held it in 24 quarters since.
  • M. Kulyk & Associates's Amgen position peaked at $7.27M in Q3 2024.
  • 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on M. Kulyk & Associates's 13F filing for Q3 2026, filed 10 Nov 2026.